直 Japanese PDF Font
  • 弁護士等
  • 業務内容
  • 論文等
  • オフィス
  • 事務所概要
  • 採用情報
Finnegan
  • 最新情報
  • Finneganについて
  • History
    • Finnegan VISION
    • Finnegan FORWARD
  • プロボノ活動
  • 事務所運営管理
    • Pricing & Alternative Fee Arrangements
    • AFA Models We Offer
    • Contingency Fees
    • AI + KM

Managing Intellectual Property Recognizes Finnegan Life Sciences and Trademark Practices

March 19, 2013

FOR IMMEDIATE RELEASE

March 19, 2013

Contact:    Barbara C. McCurdy, 202.408.4047

                    Managing Partner

Managing Intellectual Property Recognizes Finnegan Life Sciences and Trademark Practices at North American IP Awards

WASHINGTON, DC - At its annual North American IP awards dinner, Managing Intellectual Property (MIP) recognized Finnegan’s diverse practice with awards in the categories of both life sciences and trademark. Finnegan won the national award for Life Sciences/Biotech Firm of the Year in the United States and earned the Trademark Contentious Firm of the Year for the U.S. nationwide category and the U.S. northeast category. In addition to the firm awards, Finnegan partner Charles E. Lipsey earned the MIP award for Outstanding IP Litigator in Virginia.

MIP is a leading source of news and analysis on all intellectual property developments worldwide. Annually, MIP conducts its IP Survey, contacting global practitioners (including in-house counsel and law firm attorneys) across 80 jurisdictions to identify and rank leading law firms in the IP field. 

About Finnegan

With more than 375 intellectual property lawyers, Finnegan is one of the largest IP law firms in the world. From offices in Washington, DC; Atlanta, Georgia; Boston, Massachusetts; Palo Alto, California; Reston, Virginia; Brussels, Belgium; Shanghai, China; Taipei, Taiwan; and Tokyo, Japan, the firm practices all aspects of patent, trademark, copyright, and trade secret law, including counseling, prosecution, licensing, and litigation. Finnegan also represents clients on IP issues related to international trade, portfolio management, the Internet, e-commerce, government contracts, antitrust, and unfair competition. For additional information on the firm, please visit www.finnegan.com.

###

Related Practices

商標及びブランド管理

Related Industries

Biotechnology

Related News

Award/Ranking

Forbes Names Finnegan Partner Erika Harmon Arner on its Inaugural 2026 America’s Top Women Lawyers List

June 5, 2026

Award/Ranking

Finnegan Earns Top Rankings in 2026 IAM Patent 1000 Guide; Nearly 60 Attorneys Ranked

May 28, 2026

Award/Ranking

Finnegan Partner Antje Brambrink Shortlisted for Women in Business Law EMEA Award

May 13, 2026

Press Release

Finnegan Secures Decisive ITC Victory for Innoscience in Final Determination

May 11, 2026

Award/Ranking

61 Finnegan Attorneys Recognized on the 2025 Capital Pro Bono Honor Roll

May 7, 2026

Award/Ranking

Associates Rank Finnegan “Best of the Best” in BTI Associate Satisfaction Survey

May 7, 2026

Commentary

Justices to Side with Generic Drugmakers in Patent Spat, Attorneys Predict

May 5, 2026

Announcement

Finnegan Partner Ningling Wang Becomes President of Licensing Executives Society International

May 4, 2026

Award/Ranking

Finnegan Wins IP Firm of the Year at the 2026 LSPN Awards

May 1, 2026

Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.

  • プライバシー
  • 免責事項
  • Legal Notices
  • Fraud Alert
  • EEO Statement
  • Cookies
  • Contact Us

© 2026 Finnegan, Henderson, Farabow, Garrett & Dunner, LLP